Christina Barrington, PharmD, vice president and chief pharmacy officer at Priority Health, a nationally recognized nonprofit health plan serving more than 1.3 million members, has been sworn in as president of the Board of Directors for the Academy of Managed Care Pharmacy (AMCP) for 2024-2025.
The Academy of Managed Care Pharmacy (AMCP) today launched the AMCP Research Institute (ARI), a research-based resource that will conduct and facilitate projects important to the mission of managed care pharmacy. Incorporating AMCP’s existing Biologics & Biosimilars Collective Intelligence Consortium (BBCIC), the ARI will expand the scope of research opportunities for AMCP, thereby helping to advance the larger goal of improving public health in the United States.
AMCP Foundation partners with Moda Health and Novo Nordisk Inc., launching a Health Disparities Research Internship and selects Daria Sinclair of Howard University to be the first Health Disparities Research Intern.
AMCP has chosen Iulia Opran, a PharmD/MS candidate, as its 2024–2025 Executive Fellow in Health Care Association Leadership. Her diverse pharmacy background and passion for managed care make her a valuable addition to the program, which begins on July 1, 2024.
As part of AMCP Foundation's efforts to train managed care pharmacists in specialized care practices, Raquel Erb, a PharmD candidate at the University of Texas at Austin, College of Pharmacy, completed our inaugural internship sponsored by Sanofi, studying and optimizing the benefit design of specialty drugs.
The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) today announced that it has been awarded a $1.4 million grant from the Food & Drug Administration (FDA) to enable biosimilar research.
AMCP applauds the 10th Circuit for protecting the vital functions of ERISA & Medicare Part D, which provide essential services to workers and seniors, in yesterday’s ruling in the case of @PCMA v. Glen Mulready.
The AMCP Format public comment period facilitates an exchange of information between manufacturers and health care decision-makers to inform formulary and coverage decisions.
The AMCP Foundation has posthumously awarded the 2023 Steven G. Avey Award to Judith A. Cahill, former CEO of AMCP, for her sustained and exemplary service to the practice of pharmacy. Cahill's legacy includes creating the Pharmacy Quality Alliance, the AMCP Format for Formulary Submissions, and championing the passing of the Medicare Modernization Act and the Affordable Care Act. The award was accepted by AMCP past president Marissa Schlaifer, AMCP Foundation president Annesha White, and Cahill's niece Kathy Kurek at AMCP 2023.
The AMCP Foundation and its partners have announced the winners of the 23rd Annual National Student Pharmacist Pharmacy & Therapeutics Competition, where teams from across the country developed a drug monograph and recommendations for formulary placement. The University of Connecticut School of Pharmacy took first place, followed by the University of Washington School of Pharmacy and the University of Minnesota College of Pharmacy.
Congratulations to Bilqees Fatima, Adaeze Amaefule, and Yuqi Lan, the recipients of AMCP Foundation’s Best Poster Awards at AMCP 2023. This semiannual competition, proudly presented by AMCP Foundation with support from CVS Health, culminates twice a year at AMCP national meetings.
AMCP welcomes the introduction of the Equitable Community Access to Pharmacist Services Act of 2023. This legislation would help improve health equity and combat public health threats.
Sanchita Galgalikar, MBA, BS, will serve as the 2023–2024 Executive Fellow in Health Care Association Leadership. This year-long training program provides a rich, in-depth learning experience for pharmacists interested in health care association leadership or managed care pharmacy.
AMCP applauds the introduction of the Access to Prescription Digital Therapeutics Act of 2023 into the Senate and House by a bipartisan group of Senators and Representatives. The bill would authorize coverage of prescription digital therapeutics by Medicare and Medicaid, helping millions of Americans receive innovative care to treat a growing range of conditions and illnesses.
AMCP applauds Congress for passing the Pre-approval Information Exchange (PIE) Act of 2022. This bipartisan bill will enhance proactive information-sharing on new treatments between drug manufacturers and health plans.